These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6294757)

  • 21. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial forms of vitamin D-resistant rickets revisited. X-linked hypophosphatemia and autosomal recessive vitamin D dependency.
    Fraser D; Scriver CR
    Am J Clin Nutr; 1976 Nov; 29(11):1315-29. PubMed ID: 187056
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal hypophosphatemic rickets - a review.
    Chan JC
    Int J Pediatr Nephrol; 1982 Dec; 3(4):305-10. PubMed ID: 6762360
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of medical therapy on dentin formation in vitamin D-resistant rickets.
    Seow WK
    Pediatr Dent; 1991; 13(2):97-102. PubMed ID: 1652747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets.
    Marie PJ; Glorieux FH
    Calcif Tissue Int; 1983 Jul; 35(4-5):443-8. PubMed ID: 6311372
    [No Abstract]   [Full Text] [Related]  

  • 26. Hypophosphatemic rickets: still misdiagnosed and inadequately treated.
    Greene WB; Kahler SG
    South Med J; 1985 Oct; 78(10):1179-84. PubMed ID: 2996152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vitamin-D-resistant rickets: results of 12 months combined vitamin D and phosphate therapy].
    Krohn HP; Brandis M; Brodehl J; Offner G
    Monatsschr Kinderheilkd (1902); 1976 May; 124(5):417-9. PubMed ID: 180401
    [No Abstract]   [Full Text] [Related]  

  • 28. [Attempt at studying calcium-phosphorus metabolism in vitamin-D-resistant rickets (phosphatic diabetes)].
    Planeta-Malecka I; Kluska J; Konopińska H
    Wiad Lek; 1971 Dec; 24(23):2173-9. PubMed ID: 4334392
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
    Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
    Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypophosphatemic vitamin D resistant rickets treatment with one alpha hydroxy vitamin D3.
    Tragler A; Pai BU
    Indian Pediatr; 1989 Apr; 26(4):386-8. PubMed ID: 2557284
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of treatment on growth and deformity in hypophosphatemic vitamin D-resistant rickets.
    Loeffler RD; Sherman FC
    Clin Orthop Relat Res; 1982; (162):4-10. PubMed ID: 6279346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypophosphataemic vitamin D-resistant rickets; an observation on height and serum inorganic phosphate in untreated cases.
    Steendijk R; Latham SC
    Helv Paediatr Acta; 1971 Jun; 26(2):179-84. PubMed ID: 4333257
    [No Abstract]   [Full Text] [Related]  

  • 33. Inadequate bone response to phosphate and vitamin D in familial hypophosphatemic rickets (FHR).
    Glorieux FH; Bordier PJ; Marie P; Delvin EE; Travers R
    Adv Exp Med Biol; 1978; 103():227-32. PubMed ID: 213951
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tertiary hyperparathyroidism during the treatment of familial hypophosphatemic rickets].
    Moreno Molina JA; López Siguero JP; Bueno Fernández A; Martínez-Aedo Ollero MJ; Martínez Valverde A
    An Esp Pediatr; 1996 Aug; 45(2):193-5. PubMed ID: 8967654
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Fraser D; Kooh SW; Kind HP; Holick MF; Tanaka Y; DeLuca HF
    N Engl J Med; 1973 Oct; 289(16):817-22. PubMed ID: 4357855
    [No Abstract]   [Full Text] [Related]  

  • 36. Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets.
    Brickman AS; Coburn JW; Kurokawa K; Bethune JE; Harrison HE; Norman AW
    N Engl J Med; 1973 Sep; 289(10):495-8. PubMed ID: 4353218
    [No Abstract]   [Full Text] [Related]  

  • 37. VITAMIN-D RESISTANT RICKETS. A LONG-TERM CLINICAL STUDY OF 11 PATIENTS.
    TAPIA J; STEARNS G; PONSETI IV
    J Bone Joint Surg Am; 1964 Jul; 46():935-58. PubMed ID: 14192506
    [No Abstract]   [Full Text] [Related]  

  • 38. Jejunal calcium transport in health and metabolic bone disease: Effect of vitamin D.
    Soergel KH; Mueller KH; Gustke RF; Geenen JE
    Gastroenterology; 1974 Jul; 67(1):28-34. PubMed ID: 4366285
    [No Abstract]   [Full Text] [Related]  

  • 39. Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D.
    Chaussain-Miller C; Sinding C; Wolikow M; Lasfargues JJ; Godeau G; Garabédian M
    J Pediatr; 2003 Mar; 142(3):324-31. PubMed ID: 12640383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphate administration enhances the action of 1,25(OH)2D3 in familial hypophosphatemic vitamin D resistant rickets.
    Seino Y; Tanaka H; Yamaoka K
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():92-5. PubMed ID: 1338453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.